Global Hormone Replacement Therapy Market Growth ascribed to the Growing Post-Menopausal Issue Awareness

Inkwood Research estimates that the Global Hormone Replacement Therapy Market is evaluated to grow with a CAGR of 7.67% in terms of revenue during the forecasted period of 2021-2028.

"Browse 53 Market Data Tables and 46 Figures spread over 204 Pages, along with an in-depth TOC on the Global Hormone Replacement Therapy Market Forecast 2021-2028."

REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/hormone-replacement-therapy-market#request-free-sample

Hormone replacement therapy (HRT) balances progesterone and estrogen levels during menopause. It also helps alleviate hot flashes, sweating, and other menopause symptoms, and minimize osteoporosis risks.

Prevailing Awareness about Post-Menopausal Issues drives Market Growth

Adequate health education has increased the awareness of health problems during menopause to 88-98% globally. As per the clinical trials by the Journal of Education and Health Promotion, structured education and knowledge helped women develop a positive attitude towards post-menopausal issues. As a result, proper health education programs about menopause are increasingly recommended. Moreover, the growing awareness of HRT is observed among women attending primary healthcare centers in Western Saudi Arabia. Such factors are projected to boost the market growth.

VIEW TABLE OF CONTENT LINK - https://www.inkwoodresearch.com/reports/hormone-replacement-therapy-market#table-of-content

Estrogen Hormone Replacement Therapy: The Major Therapy Type

Estrogen replacement therapy (ERT) or estrogen hormone replacement therapy entails estrogen hormones commonly used to treat menopause symptoms and lessen the post-menopausal symptoms like night sweats, hot flashes, itching, burning, discomfort during sexual intercourse, and vaginal dryness. Estrogen is available in several forms. These include skin patches, gels, creams, sprays, and pills.

There have been significant developments in ERT. Innovative drug delivery systems like vaginal estrogen products and transdermal estrogen patches facilitate safe treatment options. Also, the US FDA (Food and Drug Administration) approval for many estrogen hormone products propels the ERT segment growth. Femoston (estradiol and dydrogesterone), Diane-35 (cyproterone acetate and ethinyl estradiol) (Bayer AG), Vivelle-Dot (estradiol transdermal system) (Novartis International AG), etc., are among the commercially available products in the market.

Asia-Pacific: The Fastest-Growing Region

The Asia-Pacific houses a surging elderly population. This is one of the dominant factors propelling the market growth. The increasing need for hormone replacement therapy in the region is accredited to rising awareness among end-users and enhanced healthcare infrastructure in accordance with menopausal and hormonal disorders. Novel formulations, reimbursement policies, and rising awareness on post-menopausal stress and complications, are among important growth drivers.

The intense competitive rivalry is attributed to aggressive marketing campaigns by players. ANI Pharmaceuticals, Genentech Inc, Ipsen, Amgen, Bayer AG, etc.

BUY NOW- https://www.inkwoodresearch.com/reports/hormone-replacement-therapy-market

Related Reports:

GLOBAL CYSTIC FIBROSIS THERAPEUTICS MARKET (https://inkwoodresearch.com/reports/cystic-fibrosis-therapeutics-market/)

GLOBAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET (https://inkwoodresearch.com/reports/negative-pressure-wound-therapy-devices-market/)

GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET (https://inkwoodresearch.com/reports/dermatological-therapeutics-market/)

Inkwood Research
169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857)293-0150
Email: sales@inkwoodresearch.com
Website: www.inkwoodresearch.com

We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.

This release was published on openPR.